Difference between revisions of "Mifamurtide (Mepact)"
Jump to navigation
Jump to search
m |
m |
||
| Line 12: | Line 12: | ||
[[Category:Drugs]] | [[Category:Drugs]] | ||
| + | [[Category:Synthetic muramyl dipeptides]] | ||
| + | |||
[[Category:Osteosarcoma medications]] | [[Category:Osteosarcoma medications]] | ||
[[Category:EMA approved in 2009]] | [[Category:EMA approved in 2009]] | ||
[[Category:Stub]] | [[Category:Stub]] | ||
Latest revision as of 12:16, 23 September 2023
Mechanism of action
Fully synthetic derivative of muramyl dipeptide (MDP)
Diseases for which it is used
History of changes in EMA indication
- 2009-03: Initial marketing authorisation
Also known as
- Brand name: Mepact